SW
RMD icon

SkyOak Wealth’s ResMed RMD Stock Holding History

SkyOak Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Sell
921
-81
-8% -$20.2K 0.04% 238
2025
Q4 		$241K Sell
1,002
-42
-4% -$10.7K 0.04% 213
2025
Q3 		$286K Sell
1,044
-40
-4% -$10.9K 0.05% 195
2025
Q2 		$280K Hold
1,084
– – 0.06% 187
2025
Q1 		$243K Buy
+1,084
New +$253K 0.05% 202

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SkyOak Wealth's RMD Position: Q1 2026 in Review

SkyOak Wealth reduced its ResMed (RMD) stake by 8.1% in Q1 2026, selling an estimated $20.2K and leaving 921 shares worth $207K. The position accounts for 0.04% of the portfolio, ranked #238.

SkyOak Wealth first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $286K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • SkyOak Wealth held 921 shares of ResMed worth $207K as of Q1 2026.
  • SkyOak Wealth sold 81 ResMed shares in Q1 2026, an estimated $20.2K.
  • ResMed made up 0.04% of SkyOak Wealth's portfolio in Q1 2026, its #238 holding.
  • SkyOak Wealth first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • SkyOak Wealth's ResMed position peaked at $286K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SkyOak Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.